A Study to Evaluate the Safety and Ability of the Vaccine to Induce Antibodies Against the Respiratory Syncytial Virus in Healthy Adults

计划入组 288 人 · 首次发布于 2014 年 11 月 21 日

Phase I Study for SynGEM, an Intranasal Respiratory Syncytial Virus (RSV) Prefusion F Subunit Candidate Vaccine

计划入组 48 人 · 首次发布于 2016 年 11 月 8 日

RSV F Dose-Ranging Study in Women

计划入组 720 人 · 首次发布于 2013 年 10 月 11 日

Respiratory syncytial virus vaccine(Moderna Therapeutics)

RSV-F

Ad5.RSV-F

RSV Therapeutics LLC

Casper, Dr Robert F

Canada

Schiff, Carl F MD

United States

Health Canada Approves Moderna's mRNA RSV Vaccine mRESVIA

FDA Updates: Approvals for RSV Vaccine, Pneumococcal Vaccine, and TB Drug Alongside Device Recalls

GSK's Arexvy Receives Expanded Approval in Japan for RSV Prevention in Adults Aged 50-59